Atlas market file · Equity · United States
Akanda Corp.AKAN
- Last close
- 5.36
- Change
- +6.56%
- 96-bar range
- 2.2973 – 78.9
- As of
- 6 Aug 2026
Akanda Corp. is a medicinal chemicals & botanical products issuer listed as AKAN on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
AKAN
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-97.18% over the window).
Source rail: Yahoo Finance chart API (AKAN). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for AKAN. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
AKAN public profile
Medicinal chemicals & botanical products issuer. Akanda Corp. is connected to current market context, cited company sources and its retained research file.
Akanda Corp. trades as AKAN on NASDAQ. Akanda Corp. (AKAN) has a latest verified close of 5.36, up 6.56%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files AKAN under USA Stocks for browsing.
What changed for Akanda Corp. today
Akanda Corp. (AKAN) announced plans to expand its cellular tower network by up to 20 units to 'accelerate recurring revenue,' though the company has not disclosed current tower counts or revenue metrics. The move comes alongside efforts to secure a full cultivation license for THC products, requiring Health Canada-compliant security infrastructure.
The company operates cannabis subsidiaries in Canada, focusing on cultivation and distribution of wellness products. Despite ambitious growth rhetoric, the evidence provides no financial figures on revenue, cash flow, or profitability, leaving investors to parse between platform promises and operational reality.
Recent filings highlight risks including regulatory delays, capital expenditure needs, and execution challenges. Catalysts include securing the full cultivation license, completion of security build-outs, and market acceptance of new products. The lack of disclosed financial data limits visibility into the company’s ability to fund these initiatives.
The stock’s market mechanism hinges on speculative growth assumptions, with no clear liquidity or trading volume data provided. Risks remain tied to regulatory outcomes and the company’s ability to monetize its planned expansions.
Sources & evidence · 5 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
AKAN technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on AKAN
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep AKAN research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AKAN FAQ
What is Akanda Corp. (AKAN)?Akanda Corp. (AKAN) has a latest verified close of 5.36, up 6.56%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Akanda Corp. (AKAN) has a latest verified close of 5.36, up 6.56%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for AKAN?Akanda Corp. (AKAN) has a latest verified close of 5.36, up 6.56%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the...
Akanda Corp. (AKAN) has a latest verified close of 5.36, up 6.56%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files AKAN under USA Stocks for browsing.
How often is the AKAN page updated?The AKAN public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The AKAN public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for AKAN?The AKAN file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:AKAN. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The AKAN file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:AKAN. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on AKAN?Yes. The workstation can open AKAN, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AKAN, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AKAN page investment advice?No. The AKAN page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The AKAN page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →